-
February 3, 2022
Bladder Cancer Clinical Trials at UCSD Bookmark
George Lundberg, MDEnrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Diego, keeps a running list of clinical trials offered there that are currently enrolling people with bladder cancer.
.
-
February 3, 2022
Transitional Cell Carcinoma Clinical Trials at UCSF Bookmark
George Lundberg, MDEnrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Francisco, keeps a running list of clinical trials offered there that are currently enrolling people with transitional cell carcinoma, the most common form of bladder cancer.
.
-
January 31, 2022
NCCN Guidelines for Patients: Peripheral T-Cell Lymphoma Bookmark
George Lundberg, MDThe nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for peripheral T-cell lymphoma (PTCL).
.
-
January 31, 2022
NCCN Guidelines for Patients: Acute Myeloid Leukemia Bookmark
George Lundberg, MDThe nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for acute myeloid leukemia.
.
-
January 31, 2022
NCCN Guidelines for Patients: Small Cell Lung Cancer Bookmark
George Lundberg, MDThe nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for small cell lung cancer.
.
-
January 31, 2022
NCCN Guidelines for Patients: Cervical Cancer Bookmark
George Lundberg, MDThe nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for cervical cancer.
.
-
January 31, 2022
NCCN Guidelines for Patients: Kidney Cancer Bookmark
George Lundberg, MDThe nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for kidney cancer.
.
-
January 11, 2022
Cardiometabolic Medications That Inhibit mTOR Might Help Prevent or Treat Cancer
With:Many people believe that cancer is a metabolic disease. A biological process known as the mTOR pathway controls cellular metabolism by way of central signaling, and it is involved in tumor growth. Here, our Curious Dr. George asks William H. Bestermann Jr, MD, an internal medicine doctor, how medications that target the protein mTOR and its associated pathway could prevent or treat cancer. Dr.… Read more »
-
November 22, 2021
Using Virtual Trials to Screen for Potential Glioblastoma Therapies
With: Al Musella, DPMThe existing drug development system “has failed miserably” for people with glioblastoma brain tumors, according to Al Musella, DPM, President of the Musella Foundation for Brain Tumor Research & Information, Inc. In partnership with Cancer Commons, his organization’s Brain Tumor Virtual Trial aims to speed discovery of promising new glioblastoma treatments. Curious Dr. George: How might your Virtual Trial approach speed the process toward… Read more »
-
November 10, 2021
New Targeted Treatment Options for Non-Small Cell Lung Cancer in 2021
Emma Shtivelman, PhDChemotherapy was once the only treatment available for metastatic or advanced non-small lung cancer (NSCLC). But the situation has changed dramatically in recent years. NSCLC may harbor mutations that drive cancer development, and many of these mutations can be targeted with precision drugs that inhibit specific mutant proteins. Targeted drugs not only often prolong survival of patients compared to chemotherapy, but they also improve… Read more »
Treatment Options
Learn about the latest treatments for advanced cancer. We’ve got it covered, from new FDA approvals to emerging approaches in immunotherapy, targeted therapy, cancer vaccines, modified viruses, and more.
